» Articles » PMID: 36389416

The Biological Function of M6A Methyltransferase KIAA1429 and Its Role in Human Disease

Overview
Journal PeerJ
Date 2022 Nov 17
PMID 36389416
Authors
Affiliations
Soon will be listed here.
Abstract

KIAA1429 is a major m6A methyltransferase, which plays important biological and pharmacological roles in both human cancer or non-cancer diseases. KIAA1429 produce a tumorigenic role in various cancers through regulating DAPK3, ID2, GATA3, SMC1A, CDK1, SIRT1 and other targets, promoting cell proliferation, migration, invasion, metastasis and tumor growth . At the same time, KIAA1429 is also effective in non-tumor diseases, such as reproductive system and cardiovascular system diseases. The potential regulatory mechanism of KIAA1429 dependent on m6A modification is related to mRNA, lncRNA, circRNA and miRNAs. In this review, we summarized the current evidence on KIAA1429 in various human cancers or non-cancer diseases and its potential as a prognostic target.

Citing Articles

The regulatory role of KIAA1429 in epithelial-mesenchymal transition in cervical cancer via mediating m6A modification of BTG2.

Wang M, Wang Z, Zou X, Yang D, Xu K Cytotechnology. 2025; 77(1):34.

PMID: 39760059 PMC: 11699186. DOI: 10.1007/s10616-024-00694-3.


Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review).

Qiu W, Akanyibah F, Xia Y, Ocansey D, Mao F, Liang Y Int J Mol Med. 2024; 55(2).

PMID: 39704210 PMC: 11670865. DOI: 10.3892/ijmm.2024.5474.


RNA m6A methylation regulatory mechanism of resveratrol in premature senescence cells.

Zhang X, Zhu C, Zhang L, Tan L, Cheng W, Li M Food Sci Nutr. 2024; 12(11):9238-9251.

PMID: 39619978 PMC: 11606896. DOI: 10.1002/fsn3.4487.


Role of the mA demethylase ALKBH5 in gastrointestinal tract cancer (Review).

Zhang L, Jing M, Song Q, Ouyang Y, Pang Y, Ye X Int J Mol Med. 2024; 55(2).

PMID: 39611478 PMC: 11637504. DOI: 10.3892/ijmm.2024.5463.


Insights into the role of N6-methyladenosine (m6A) in plant-virus interactions.

Secco N, Sheikh A, Hirt H J Virol. 2024; 99(1):e0159824.

PMID: 39570081 PMC: 11784248. DOI: 10.1128/jvi.01598-24.


References
1.
Yang D, Chang S, Li F, Ma M, Yang J, Lv X . m A transferase KIAA1429-stabilized LINC00958 accelerates gastric cancer aerobic glycolysis through targeting GLUT1. IUBMB Life. 2021; 73(11):1325-1333. DOI: 10.1002/iub.2545. View

2.
Wang M, Yang Y, Yang J, Yang J, Han S . circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of mA-YTHDF3-Zeb1. Life Sci. 2020; 257:118082. DOI: 10.1016/j.lfs.2020.118082. View

3.
Izadi S, Nikkhoo A, Hojjat-Farsangi M, Namdar A, Azizi G, Mohammadi H . CDK1 in Breast Cancer: Implications for Theranostic Potential. Anticancer Agents Med Chem. 2020; 20(7):758-767. DOI: 10.2174/1871520620666200203125712. View

4.
Barros-Silva D, Lobo J, Guimaraes-Teixeira C, Carneiro I, Oliveira J, Martens-Uzunova E . VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer. Cancers (Basel). 2020; 12(4). PMC: 7226055. DOI: 10.3390/cancers12040771. View

5.
Sun X, Dai G, Yu L, Hu Q, Chen J, Guo W . miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2. Sci Rep. 2018; 8(1):606. PMC: 5766605. DOI: 10.1038/s41598-017-18739-3. View